Navigation Links
Reaction To ADHD Medication May Be Genetic By Nature

New research points out that the difference in genes might be responsible for the way patients suffering from attention deficit hyperactivity disorder (ADHD) differ in reacting to medications. //

The study, done by the researchers from University of Illinois at Chicago, had found that children with a variant form of a dopamine transporter gene -- a variant known to be associated with ADHD -- responded poorly to one of the most common stimulant medications, methylphenidate. The transporter gene encodes a protein on the nerve cell membrane that helps to clear the neurotransmitter dopamine from the nerve junction.

The researchers had first reported an association of this gene with ADHD 10 years ago. In the new study, they had examined the relationship between the gene and patients' medication response over a four-week period, first on a placebo and then on three increasing dosages of methylphenidate.

The researchers tested 47 children with ADHD between 5 and 16 years old to determine which variant of the dopamine transporter gene they carried. They focused on two specific variants -- called 9R and 10R -- of the transporter gene and evaluated how varying doses of methylphenidate would affect ADHD symptoms, impairment, and stimulant side effects.

The majority of the patients had one or two copies of the 10R variant. Of these children, nearly 60 percent had excellent response to the highest dosage (54 milligrams). In contrast, of the patients with two copies of the 9R variant, none displayed such dramatic improvement.

Results of the current study appear in the July issue of the journal Neuropsychopharmachology.

Source: Newswise
'"/>




Page: 1

Related medicine news :

1. Diet Can Influence Allergic Skin Reactions
2. Influence of diet on allergic Reactions
3. Red Color Causes The Allergic Reaction To Strawberries
4. New Insight Gained For Allergic Reactions
5. Emergency Treatment Found Wanting In Anaphylactic Reactions
6. Cancer Causing Proteins Trigger Abnormal Biochemical Reactions In Cells
7. New Medicare Plan - Mixed Reaction among Pharmacists.
8. Drug Reactions First Present Themselves In The Mouth
9. Eye Drug Macugen Shows Allergic Reactions
10. Gender Difference In Reaction To Cancer
11. Mouse Model Demonstrates Immune System Reaction In Chlamydia Infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: